Background In March 2016, one of our hospital pharmacies started using a robotic solution for chemotherapy compounding. This solution was placed in a production room with an EU-GMP class D classification. During an audit related to the start-up, our governing body requested to see results to determine if the robotic solution could uphold the EU-GMP classification for its respective areas, and sustain the same level of microbiological cleanliness as manual production done in an isolator.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile